Phase I/II/III Pharmacokinetic and Outcome Study of Insp

Project: Research project

Description

Phase I/II/III Pharmacokinetic and Outcome Study of Inspiration's Recombinant Factor IX Product, IB1001, in Subjects with Hemophilia B
StatusActive
Effective start/end date5/14/1012/31/20

Funding

  • Inspiration Biopharmaceuticals, Inc.

Fingerprint

Hemophilia B
Factor IX
Pharmacokinetics
Outcome Assessment (Health Care)
IB1001